|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM HORIZON
PHARMACIES, INC. - 10-Q FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 3,836
<SECURITIES> 0
<RECEIVABLES> 13,002
<ALLOWANCES> (696)
<INVENTORY> 20,488
<CURRENT-ASSETS> 38,107
<PP&E> 10,277
<DEPRECIATION> (2,496)
<TOTAL-ASSETS> 61,388
<CURRENT-LIABILITIES> 42,663
<BONDS> 8,229
0
0
<COMMON> 60
<OTHER-SE> 10,436
<TOTAL-LIABILITY-AND-EQUITY> 61,388
<SALES> 104,036
<TOTAL-REVENUES> 104,036
<CGS> 77,593
<TOTAL-COSTS> 108,656
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,030
<INCOME-PRETAX> (6,650)
<INCOME-TAX> 0
<INCOME-CONTINUING> (6,650)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,650)
<EPS-BASIC> (1.12)
<EPS-DILUTED> (1.12)
</TABLE>
|
|